Matthew C. Wright

4.4k total citations
104 papers, 3.7k citations indexed

About

Matthew C. Wright is a scholar working on Hepatology, Pharmacology and Surgery. According to data from OpenAlex, Matthew C. Wright has authored 104 papers receiving a total of 3.7k indexed citations (citations by other indexed papers that have themselves been cited), including 49 papers in Hepatology, 28 papers in Pharmacology and 26 papers in Surgery. Recurrent topics in Matthew C. Wright's work include Liver physiology and pathology (38 papers), Pharmacogenetics and Drug Metabolism (26 papers) and Drug Transport and Resistance Mechanisms (18 papers). Matthew C. Wright is often cited by papers focused on Liver physiology and pathology (38 papers), Pharmacogenetics and Drug Metabolism (26 papers) and Drug Transport and Resistance Mechanisms (18 papers). Matthew C. Wright collaborates with scholars based in United Kingdom, United States and Egypt. Matthew C. Wright's co-authors include Karen Wallace, Derek A. Mann, Alan J. Paine, Alastair D. Burt, Carylyn J. Marek, John P. Iredale, Michael J.P. Arthur, Fiona Oakley, Agneta Oskarsson and Graeme I. Murray and has published in prestigious journals such as Journal of Biological Chemistry, Nature Medicine and SHILAP Revista de lepidopterología.

In The Last Decade

Matthew C. Wright

103 papers receiving 3.6k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Matthew C. Wright United Kingdom 33 1.5k 1.1k 923 667 622 104 3.7k
Pierre Brissot France 57 1.0k 0.7× 1.6k 1.4× 1.3k 1.4× 531 0.8× 576 0.9× 305 12.1k
Antonello Pietrangelo Italy 59 1.1k 0.7× 1.5k 1.3× 1.6k 1.8× 604 0.9× 371 0.6× 193 11.5k
Christian Rust Germany 32 1.6k 1.1× 1.8k 1.6× 696 0.8× 1.1k 1.6× 1.2k 1.9× 64 3.8k
Concetta Tuccillo Italy 30 567 0.4× 1.2k 1.1× 1.2k 1.3× 667 1.0× 453 0.7× 97 3.8k
Pascal Loyer France 35 822 0.6× 505 0.4× 1.8k 1.9× 478 0.7× 924 1.5× 100 3.9k
Jan Snoeys Belgium 33 670 0.4× 372 0.3× 1.2k 1.4× 529 0.8× 897 1.4× 94 3.7k
Ming‐Chin Yu Taiwan 32 896 0.6× 622 0.5× 975 1.1× 789 1.2× 634 1.0× 131 3.3k
Wei Tang China 38 818 0.5× 725 0.6× 2.1k 2.3× 412 0.6× 945 1.5× 177 4.6k
Tadashi Ikegami Japan 28 556 0.4× 846 0.7× 962 1.0× 880 1.3× 743 1.2× 110 2.7k
Chenghai Liu China 29 934 0.6× 958 0.8× 931 1.0× 254 0.4× 262 0.4× 154 2.8k

Countries citing papers authored by Matthew C. Wright

Since Specialization
Citations

This map shows the geographic impact of Matthew C. Wright's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Matthew C. Wright with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Matthew C. Wright more than expected).

Fields of papers citing papers by Matthew C. Wright

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Matthew C. Wright. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Matthew C. Wright. The network helps show where Matthew C. Wright may publish in the future.

Co-authorship network of co-authors of Matthew C. Wright

This figure shows the co-authorship network connecting the top 25 collaborators of Matthew C. Wright. A scholar is included among the top collaborators of Matthew C. Wright based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Matthew C. Wright. Matthew C. Wright is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Wright, Matthew C., Tiffany Caza, Valérie Garcia, et al.. (2025). G1 and G2 ApolipoproteinL1 modulate macrophage inflammation and lipid accumulation through the polyamine pathway. 1 indexed citations
2.
Abdelghany, Tarek M., et al.. (2024). Methylimidazolium ionic liquids - A new class of forever chemicals with endocrine disrupting potential. Chemosphere. 363. 142827–142827.
3.
Abdelghany, Tarek M., et al.. (2024). Ionic Liquid 1-Octyl-3-Methylimidazolium (M8OI) Is Mono-Oxygenated by CYP3A4 and CYP3A5 in Adult Human Liver. SHILAP Revista de lepidopterología. 14(3). 907–922. 2 indexed citations
4.
5.
Abdelghany, Tarek M., et al.. (2022). Potential for cardiac toxicity with methylimidazolium ionic liquids. Ecotoxicology and Environmental Safety. 249. 114439–114439. 8 indexed citations
6.
Ibrahim, Ibrahim, Tarek M. Abdelghany, Alex Charlton, et al.. (2021). The methylimidazolium ionic liquid M8OI is detectable in human sera and is subject to biliary excretion in perfused human liver. Toxicology. 459. 152854–152854. 21 indexed citations
7.
Sen, Gourab, Jeremy French, Colin Wilson, et al.. (2019). The association of pregnane X receptor activation with outcomes after liver transplantation—A retrospective study. Clinical Transplantation. 33(12). e13734–e13734. 4 indexed citations
8.
Abdelghany, Tarek M., Jeremy M. Palmer, Martin P. Cooke, et al.. (2019). The toxicity of the methylimidazolium ionic liquids, with a focus on M8OI and hepatic effects. Food and Chemical Toxicology. 136. 111069–111069. 67 indexed citations
9.
Lakey, A., Tarek M. Abdelghany, Ibrahim Ibrahim, et al.. (2018). HNF4alpha expression amplifies the glucocorticoid-induced conversion of a human pancreatic cell line to an hepatocyte-like cell. Biochemical and Biophysical Research Communications. 503(3). 1633–1640. 1 indexed citations
10.
Palmer, Jeremy M., Tarek M. Abdelghany, A. Lakey, et al.. (2018). Identification of a xenobiotic as a potential environmental trigger in primary biliary cholangitis. Journal of Hepatology. 69(5). 1123–1135. 70 indexed citations
11.
Lakey, A., Faith M. Williams, Paul A. Jowsey, et al.. (2017). Hepatic effects of tartrazine (E 102) after systemic exposure are independent of oestrogen receptor interactions in the mouse. Toxicology Letters. 273. 55–68. 21 indexed citations
12.
AlQuadeib, Bushra T., Mahasen A. Radwan, Lidija Šiller, Benjamin R. Horrocks, & Matthew C. Wright. (2014). Stealth Amphotericin B nanoparticles for oral drug delivery: In vitro optimization. Saudi Pharmaceutical Journal. 23(3). 290–302. 65 indexed citations
13.
Chung, Git, Simon Cockell, Loranne Agius, et al.. (2013). Utility of B-13 Progenitor-Derived Hepatocytes in Hepatotoxicity and Genotoxicity Studies. Toxicological Sciences. 137(2). 350–370. 17 indexed citations
14.
15.
Wright, Matthew C., Richard Grieve, John P. Roberts, Janice Main, & Howard Thomas. (2006). Health benefits of antiviral therapy for mild chronic hepatitis C: randomised controlled trial and economic evaluation. Health Technology Assessment. 10(21). 1–113, iii. 201 indexed citations
16.
Elrick, Lucy J., et al.. (2004). Identification of a truncated ratp28-related protein expressed in kidney. Biochemical and Biophysical Research Communications. 316(3). 872–877. 8 indexed citations
17.
Cameron, Gary A., Carylyn J. Marek, Emma Louise Haughton, et al.. (2004). Mechanism of action of the antifibrogenic compound gliotoxin in rat liver cells. Hepatology. 40(1). 232–242. 56 indexed citations
18.
Trim, Julie E., Michael J.P. Arthur, Matthew C. Wright, et al.. (2000). Upstream Tissue Inhibitor of Metalloproteinases-1 (TIMP-1) Element-1, a Novel and Essential Regulatory DNA Motif in the Human TIMP-1 Gene Promoter, Directly Interacts with a 30-kDa Nuclear Protein. Journal of Biological Chemistry. 275(9). 6657–6663. 51 indexed citations
19.
20.
CROS, S., et al.. (1989). Experimental antitumor activity of Navelbine.. PubMed. 16(2 Suppl 4). 15–20. 117 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Pierre Brissot Breakdown of academic impact, for papers by Antonello Pietrangelo Breakdown of academic impact, for papers by Christian Rust Breakdown of academic impact, for papers by Concetta Tuccillo Breakdown of academic impact, for papers by Pascal Loyer Breakdown of academic impact, for papers by Jan Snoeys Breakdown of academic impact, for papers by Ming‐Chin Yu Breakdown of academic impact, for papers by Wei Tang Breakdown of academic impact, for papers by Tadashi Ikegami Breakdown of academic impact, for papers by Chenghai Liu
Rankless by CCL
2026